Chemistry - A European Journal · 2021 · 11 citations · 48 references
Natural SciencesChemistryMedicinal ChemistryCancer PharmacologyOrganometallic ChemistrySynthetic Medicinal ChemistryLigand BindingLigand-based DesignMetal-ligand BondingPeptide ChemistryTransition Metal ChemistryTransition Metal ComplexesAnticancer ActivityFunctionalizationLigand DesignPeptide ConjugatesPeptide FunctionalizationSite-selective FunctionalizationSolid-support FunctionalizationTransition Metal Catalysts
The number of donor atoms available on peptides that can competitively coordinate to metal centers renders the site-selective generation of advanced metal-peptide conjugates in high purity a challenging venture. Herein, we present a transmetalation-based synthetic approach on solid support in which an imidazolium pro-ligand can be used to selectively anchor a range of transition metal half-sandwich complexes onto peptides in the presence of multiple coordinative motifs. Amenable to solid support, a range of N-terminus and/or lysine conjugated metal-peptide conjugates were obtained in high purity after cleavage from the resin. The metalated peptides were evaluated for their anticancer properties against human cancer cell lines. While no cytotoxic activity was observed, this platform has the potential to i) provide a pathway to site-selective peptide labelling, ii) be explored as a biorthogonal handle and/or iii) generate a new strategy for ligand design in transition metal catalysts.
48
Kesheng Zhao, Guomin Zhao, Dunli Wu et al. · Journal of Biological Chemistry · 2004 · 781 citations · Full text
Areneruthenium complexes as anticancer agents
Georg Süß‐Fink · Dalton Transactions · 2009 · 635 citations
Development of Organometallic Ruthenium−Arene Anticancer Drugs That Resist Hydrolysis
Wee Han Ang, Elisa Daldini, C. Scolaro et al. · Inorganic Chemistry · 2006 · 227 citations · Full text